• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network.与糖尿病性黄斑水肿玻璃体切除术后视力结果相关的因素:糖尿病视网膜病变临床研究网络。
Retina. 2010 Oct;30(9):1488-95. doi: 10.1097/IAE.0b013e3181e7974f.
2
Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.糖尿病性黄斑水肿玻璃体切除术后早期视网膜厚度变化及并发症
Am J Ophthalmol. 2003 Jan;135(1):14-9. doi: 10.1016/s0002-9394(02)01819-6.
3
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.对于无紧张后玻璃体后皮质的难治性糖尿病性黄斑水肿行玻璃体平坦部玻璃体切除术联合内界膜剥除术
Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):20-5. doi: 10.1007/s00417-004-0958-z. Epub 2004 Jul 31.
4
Tomographic assessment of vitreous surgery for diabetic macular edema.糖尿病性黄斑水肿玻璃体手术的断层扫描评估
Am J Ophthalmol. 2000 Apr;129(4):487-94. doi: 10.1016/s0002-9394(99)00409-2.
5
Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.伴有或不伴有内界膜剥除的玻璃体切除术治疗糖尿病性黄斑水肿
Ophthalmologica. 2005 Jul-Aug;219(4):206-13. doi: 10.1159/000085729.
6
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.糖尿病性黄斑水肿和玻璃体视网膜牵引的玻璃体切割术结果。
Ophthalmology. 2010 Jun;117(6):1087-1093.e3. doi: 10.1016/j.ophtha.2009.10.040. Epub 2010 Mar 17.
7
Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.玻璃体切割联合内界膜剥除术治疗持续性糖尿病性黄斑水肿
Am J Ophthalmol. 2005 Mar;139(3):447-54. doi: 10.1016/j.ajo.2004.09.076.
8
EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON LONG-TERM VISUAL OUTCOMES FOR DIABETIC MACULAR EDEMA.内界膜剥除术对糖尿病性黄斑水肿长期视力预后的影响
Retina. 2015 Jul;35(7):1422-8. doi: 10.1097/IAE.0000000000000497.
9
Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.经扁平部玻璃体切割术治疗后,糖尿病性黄斑水肿患者眼睛的视力得到改善。
Ophthalmologica. 2004 Nov-Dec;218(6):378-84. doi: 10.1159/000080940.
10
VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.玻璃体切除术联合内界膜剥除术治疗牵拉性和非牵拉性糖尿病性黄斑水肿:一项对比研究的长期结果
Retina. 2015 May;35(5):921-8. doi: 10.1097/IAE.0000000000000433.

引用本文的文献

1
Vitrectomy for Epiretinal Membrane Peeling in Patients with Diabetic Retinopathy-Functional and Morphological Outcome.糖尿病视网膜病变患者视网膜前膜剥除的玻璃体切除术——功能和形态学结果
J Clin Med. 2025 Jul 18;14(14):5128. doi: 10.3390/jcm14145128.
2
Ultrastructural imaging biomarkers in diabetic macular edema: A major review.糖尿病性黄斑水肿中的超微结构成像生物标志物:一项主要综述。
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S7-S23. doi: 10.4103/IJO.IJO_878_24. Epub 2024 Dec 24.
3
Diabetic Disease of the Eye in Canada: Consensus Statements from a Retina Specialist Working Group.加拿大糖尿病眼病:视网膜专科医生工作组的共识声明
Ophthalmol Ther. 2024 May;13(5):1071-1102. doi: 10.1007/s40123-024-00923-0. Epub 2024 Mar 23.
4
Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial.微创新庄玻璃体切除术联合内界膜剥除与抗 VEGF 玻璃体注射治疗初治糖尿病黄斑水肿(VVV-DME 研究):一项随机对照试验的研究方案。
Trials. 2023 Oct 24;24(1):685. doi: 10.1186/s13063-023-07735-w.
5
Pars plana vitrectomy for tractional diabetic macular edema with or without internal limiting membrane peeling.用于治疗有或无内界膜剥除的牵引性糖尿病性黄斑水肿的玻璃体切除术。
Med Hypothesis Discov Innov Ophthalmol. 2022 Dec 3;11(3):110-118. doi: 10.51329/mehdiophthal1454. eCollection 2022 Fall.
6
Current Treatments for Diabetic Macular Edema.糖尿病性黄斑水肿的当前治疗方法。
Int J Mol Sci. 2023 May 31;24(11):9591. doi: 10.3390/ijms24119591.
7
Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema.病理性神经血管单元在糖尿病性黄斑水肿的多模态成像中的定位。
Medicina (Kaunas). 2023 May 7;59(5):896. doi: 10.3390/medicina59050896.
8
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema.玻璃体内注射地塞米松植入物治疗牵拉性糖尿病性黄斑水肿 1 个月后黄斑剥除的中期安全性和有效性。
Sci Rep. 2023 Apr 12;13(1):5990. doi: 10.1038/s41598-023-32780-5.
9
Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy.与增生型糖尿病性视网膜病变患者糖尿病性黄斑水肿相关的因素。
Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2191-2200. doi: 10.1007/s00417-022-05595-9. Epub 2022 Feb 22.
10
The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis.康柏西普联合全视网膜光凝与单纯全视网膜光凝治疗糖尿病视网膜病变的疗效比较:一项Meta分析
J Ophthalmol. 2021 May 8;2021:5591719. doi: 10.1155/2021/5591719. eCollection 2021.

本文引用的文献

1
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research.一种用于临床研究的光相干断层扫描数据对数转换的方法。
Ophthalmology. 2010 Aug;117(8):1512-6. doi: 10.1016/j.ophtha.2009.12.014. Epub 2010 Apr 3.
2
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.糖尿病性黄斑水肿和玻璃体视网膜牵引的玻璃体切割术结果。
Ophthalmology. 2010 Jun;117(6):1087-1093.e3. doi: 10.1016/j.ophtha.2009.10.040. Epub 2010 Mar 17.
3
Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.弥漫性非牵引性糖尿病性黄斑水肿玻璃体切除术的长期随访
Retina. 2009 Apr;29(4):464-72. doi: 10.1097/IAE.0b013e31819c632f.
4
Vitrectomy for diabetic macular oedema.糖尿病性黄斑水肿的玻璃体切除术
Eye (Lond). 2008 Oct;22(10):1337-41. doi: 10.1038/eye.2008.84. Epub 2008 Apr 25.
5
Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome.玻璃体切除术治疗持续性糖尿病性黄斑水肿的疗效评估及预测预后的相关因素
Korean J Ophthalmol. 2007 Sep;21(3):146-50. doi: 10.3341/kjo.2007.21.3.146.
6
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.使用蔡司光学相干断层扫描技术测量糖尿病性黄斑水肿患者黄斑厚度和体积的可重复性
Ophthalmology. 2007 Aug;114(8):1520-5. doi: 10.1016/j.ophtha.2006.10.055. Epub 2007 Mar 13.
7
Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.预测糖尿病性黄斑水肿玻璃体切除术预后的因素:一项前瞻性研究的结果
Br J Ophthalmol. 2006 Jan;90(1):33-6. doi: 10.1136/bjo.2005.072934.
8
Course of vitreomacular traction syndrome.玻璃体黄斑牵引综合征的病程
Am J Ophthalmol. 1995 Jan;119(1):55-61. doi: 10.1016/s0002-9394(14)73813-9.
9
The role of the vitreous in diabetic macular edema.玻璃体在糖尿病性黄斑水肿中的作用。
Ophthalmology. 1988 Oct;95(10):1335-9. doi: 10.1016/s0161-6420(88)33004-6.

与糖尿病性黄斑水肿玻璃体切除术后视力结果相关的因素:糖尿病视网膜病变临床研究网络。

Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network.

机构信息

Oregon Health and Science University, Portland, Oregon, USA.

出版信息

Retina. 2010 Oct;30(9):1488-95. doi: 10.1097/IAE.0b013e3181e7974f.

DOI:10.1097/IAE.0b013e3181e7974f
PMID:20924264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2975977/
Abstract

PURPOSE

To evaluate factors ¶associated with favorable outcomes after vitrectomy for diabetic macular edema.

METHODS

Data were collected prospectively on 241 eyes undergoing vitrectomy for diabetic macular edema. Multivariate models were used to evaluate associations of 20 preoperative and intraoperative factors with 6-month outcomes of visual acuity and retinal thickness.

RESULTS

Median central subfield thickness decreased from 412 μm to 278 μm at 6 months, but median visual acuity remained unchanged (20/80, Snellen equivalent). Greater visual acuity improvement occurred in eyes with worse baseline acuity (P < 0.001) and in eyes in which an epiretinal membrane was removed (P = 0.006). Greater reduction in central subfield thickness occurred with worse baseline visual acuity (P < 0.001), greater preoperative retinal thickness (P = 0.001), removal of internal limiting membrane (P = 0.003), and optical coherence tomography evidence of vitreoretinal abnormalities (P = 0.006). No associations with clinician's preoperative assessments of the posterior vitreous were identified.

CONCLUSION

These results suggest that the removal of epiretinal membranes may favorably affect visual outcome after vitrectomy. Preoperative presence of vitreoretinal abnormalities appeared to be associated with somewhat greater reductions in retinal thickness but not with visual acuity outcome. These results may be useful for future studies evaluating vitrectomy for diabetic macular edema.

摘要

目的

评估玻璃体切割术治疗糖尿病性黄斑水肿后获得良好结果的相关因素。

方法

前瞻性收集 241 只接受玻璃体切割术治疗糖尿病性黄斑水肿的患眼数据。使用多变量模型评估 20 个术前和术中因素与术后 6 个月视力和视网膜厚度结果的相关性。

结果

6 个月时,中央视网膜厚度的中位数从 412μm 下降至 278μm,但视力的中位数保持不变(20/80,Snellen 等价物)。基线视力较差的眼视力改善更大(P<0.001),并且存在视网膜内界膜(ERM)的眼视力改善更大(P=0.006)。基线视力越差(P<0.001)、术前视网膜厚度越大(P=0.001)、去除内界膜(P=0.003)和光学相干断层扫描(OCT)显示存在玻璃体视网膜异常(P=0.006),中央视网膜厚度的降低越大。与临床医生对后玻璃体的术前评估无相关性。

结论

这些结果表明,去除 ERM 可能会对玻璃体切割术后的视力结果产生有利影响。术前存在玻璃体视网膜异常似乎与视网膜厚度的稍大程度降低有关,但与视力结果无关。这些结果可能对未来评估糖尿病性黄斑水肿的玻璃体切割术的研究有用。